ArticleThe British journal of surgery2026
Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study.
Article in The British journal of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients undergoing pancreatectomy for pancreatic cancer may experience gastrointestinal symptoms that impair health-related quality of life (HRQoL) before and after pancreatic surgery. The longitudinal course of these symptoms and their association with HRQoL remains unclear as large prospective studies are lacking.
methodsPatients who underwent pancreatectomy for pancreatic cancer and filled out questionnaires of the Dutch Pancreatic Cancer Project were included in this cohort study. Gastrointestinal symptoms and HRQoL were assessed before surgery and 0-3, 3-6, 6-9, and 9-12 months after surgery. Multivariable generalized linear mixed models were applied to evaluate longitudinal changes in gastrointestinal symptoms and their association with HRQoL.
resultsAfter pancreatectomy for pancreatic cancer, overall, 1009 patients were included and 2995 questionnaires were completed. Before surgery, gastrointestinal symptoms were present in 95% of patients; commonly flatulence, dry mouth, problems with taste, and altered bowel habits. Gastrointestinal symptom scores peaked at 0-3 months after surgery and generally returned to preoperative or lower levels at 9-12 months after surgery. Severe gastrointestinal symptoms (defined as 'quite a bit' or 'very much') decreased from 61% of patients before surgery to 52% at 9-12 months after surgery. Patients with two or more severe symptoms had moderate (10-20 points) to large (>20 points) clinically relevant lower scores for HRQoL.
conclusionGastrointestinal symptoms in patients undergoing pancreatectomy for pancreatic cancer were highly prevalent and peaked within 3 months after surgery. Severe gastrointestinal symptoms affected more than half of all patients after surgery, which led to substantial declines in HRQoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.